Latest Asx News

Lithium Universe Limited (ASX, LU7) reports major advances in silver recycling technology alongside plans for a second lithium refinery in Texas, supported by a $2.5 million capital raise.

Resonance Health has reported record half-year revenue and strong progress in clinical trials, alongside promising new technology deployments set to enhance its global footprint.

Pacific Lime and Cement Limited reports steady progress on its Central Lime Project in Papua New Guinea, securing key government agreements and strategic partnerships while maintaining financial discipline.

TradeWindow reports solid growth in recurring revenue and average revenue per customer but lowers its FY26 trading revenue guidance due to softer transactional volumes in Q3.

Po Valley Energy has adopted its first-ever dividend policy and announced plans to pay a maiden dividend, signalling confidence in its cash flow and future growth prospects.

ioneer Ltd has raised approximately US$50.4 million through an institutional placement to fund the advancement of its Rhyolite Ridge lithium-boron project in Nevada towards a Final Investment Decision in the second half of 2026. The capital injection supports project readiness, environmental permitting, and early works for this strategically significant US critical minerals asset.

Ioneer Ltd has raised US$50 million through a share placement to accelerate development of its Rhyolite Ridge Lithium-Boron Project, positioning itself as a key U.S. supplier of critical minerals.

FIN Resources is gearing up to launch its maiden drilling campaign at the high-grade Cabin Lake Gold Project in Canada’s Northwest Territories, with ice road construction starting in early February and drilling expected by March.

BluGlass Limited has extended its contract with the U.S. Department of War by A$1.05 million and appointed a refreshed Board to accelerate its commercial growth in visible laser technology. The company is advancing its GaN laser portfolio amid a US$100 million project pipeline and ongoing R&D investments.

Cavalier Resources has reported significant gold assay results from its Miranda Target drilling near the Crawford Gold Project, underpinning strong project economics in a revised Pre-Feasibility Study.

WAM Active Limited has announced a $51.4 million entitlement offer priced at a 7.8% discount, alongside a $19.3 million placement, aiming to capitalise on its recent robust portfolio performance and deliver attractive dividends to shareholders.

Actinogen Medical’s pivotal XanaMIA trial for Alzheimer’s disease has received a green light from its independent Data Monitoring Committee to continue, reinforcing confidence in the drug’s safety and efficacy profile.